Concentrations |
6 Months Ended |
|---|---|
Jun. 30, 2026 | |
| Concentrations [Abstract] | |
| CONCENTRATIONS | NOTE 7 – CONCENTRATIONS
Customer concentration
For the six months ended June 30, 2026 and 2025, one licensee accounted for 100% of total revenues from customer license fees.
Vendor concentrations
For the six months ended June 30, 2026 and 2025, one licensor accounted for 100% of the Company’s vendor license agreements (see Note 8) related to the Company’s biopharmaceutical operations. |